These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8602891)

  • 1. [Synthesis of retinoids with a modified polar group and their antitumor activity. Report I].
    Deriabina EL; Khodonov AA; Cherevataia GV; Kirillova IuG; Shvets VI; Kostanian IA; Astapova MV; Dranitsyna SM; Starovoń≠tova EV
    Bioorg Khim; 1995 Dec; 21(12):941-9. PubMed ID: 8602891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
    Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
    Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
    Liu S; Brown CW; Berlin KD; Dhar A; Guruswamy S; Brown D; Gardner GJ; Birrer MJ; Benbrook DM
    J Med Chem; 2004 Feb; 47(4):999-1007. PubMed ID: 14761202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthetic retinoids. Selectivity for receptors and biologic activity].
    Shroot B; Bernardon JM; Charpentier B; Reichert U
    J Pharm Belg; 1994; 49(3):221-5. PubMed ID: 8057234
    [No Abstract]   [Full Text] [Related]  

  • 5. Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structures.
    Amano Y; Noguchi M; Nakagomi M; Muratake H; Fukasawa H; Shudo K
    Bioorg Med Chem; 2013 Jul; 21(14):4342-50. PubMed ID: 23685180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel atypical retinoid endowed with proapoptotic and antitumor activity.
    Cincinelli R; Dallavalle S; Merlini L; Penco S; Pisano C; Carminati P; Giannini G; Vesci L; Gaetano C; Illy B; Zuco V; Supino R; Zunino F
    J Med Chem; 2003 Mar; 46(6):909-12. PubMed ID: 12620066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
    Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
    Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of a new series of retinoid-related biphenyl-4-ylacrylic acids endowed with antiproliferative and proapoptotic activity.
    Cincinelli R; Dallavalle S; Nannei R; Carella S; De Zani D; Merlini L; Penco S; Garattini E; Giannini G; Pisano C; Vesci L; Carminati P; Zuco V; Zanchi C; Zunino F
    J Med Chem; 2005 Jul; 48(15):4931-46. PubMed ID: 16033272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the first retinoid X, receptor homodimer antagonist.
    Canan Koch SS; Dardashti LJ; Hebert JJ; White SK; Croston GE; Flatten KS; Heyman RA; Nadzan AM
    J Med Chem; 1996 Aug; 39(17):3229-34. PubMed ID: 8765503
    [No Abstract]   [Full Text] [Related]  

  • 11. Retinoids as chemopreventive agents.
    Ralhan R; Kaur J
    J Biol Regul Homeost Agents; 2003; 17(1):66-91. PubMed ID: 12757022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
    Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Capone F; Dusonchet L; Meli M; Raimondi MV; Landino M; D'Alessandro N; Tolomeo M; Arindam D; Lu S; Benbrook DM
    J Med Chem; 2001 Jul; 44(14):2308-18. PubMed ID: 11428925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promise of retinoids to fight against cancer.
    Altucci L; Gronemeyer H
    Nat Rev Cancer; 2001 Dec; 1(3):181-93. PubMed ID: 11902573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
    Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
    J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.
    Benbrook DM; Madler MM; Spruce LW; Birckbichler PJ; Nelson EC; Subramanian S; Weerasekare GM; Gale JB; Patterson MK; Wang B; Wang W; Lu S; Rowland TC; DiSivestro P; Lindamood C; Hill DL; Berlin KD
    J Med Chem; 1997 Oct; 40(22):3567-83. PubMed ID: 9357524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic retinoids: recent developments concerning structure and clinical utility.
    Kagechika H; Shudo K
    J Med Chem; 2005 Sep; 48(19):5875-83. PubMed ID: 16161990
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene expression analysis of human promyelocytic leukemia HL-60 cell differentiation and cytotoxicity induced by natural and synthetic retinoids.
    Wang J; Fong CC; Tzang CH; Xiao P; Han R; Yang M
    Life Sci; 2009 Apr; 84(17-18):576-83. PubMed ID: 19302803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid receptor alpha mediates growth inhibition by retinoids in human colon carcinoma HT29 cells.
    Nicke B; Kaiser A; Wiedenmann B; Riecken EO; Rosewicz S
    Biochem Biophys Res Commun; 1999 Aug; 261(3):572-7. PubMed ID: 10441468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of DAAS derivatives and their enhancement of HL-60 leukemia cell differentiation.
    Kim SH; Chung SY; Kim YW; Kim TS; Choi BG
    Arch Pharm Res; 2008 Mar; 31(3):300-4. PubMed ID: 18409041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New retinoids inhibiting the growth of human acute promyelocytic leukemia cell line HL-60 without inducing differentiation.
    Suzuki T; Kawamura S; Matsui M; Murayama A
    J Nutr Sci Vitaminol (Tokyo); 1993 Jun; 39(3):221-33. PubMed ID: 8229314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.